{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T05:35:52Z","timestamp":1766208952330,"version":"3.48.0"},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,12,15]]},"DOI":"10.2169\/internalmedicine.5678-25","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:07:48Z","timestamp":1749060468000},"page":"3486-3492","source":"Crossref","is-referenced-by-count":0,"title":["Corticosteroid-induced Cushingoid Appearance in Myasthenia Gravis"],"prefix":"10.2169","volume":"64","author":[{"given":"Akiyuki","family":"Uzawa","sequence":"first","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manato","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Akamine","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neurology Chiba Clinic, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Kubota","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory and Biomedical Sciences, Division of Health Sciences, The University of Osaka Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori P.","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory and Biomedical Sciences, Division of Health Sciences, The University of Osaka Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Sendai Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genya","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Sendai Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hyogo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamichi","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Samukawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kindai University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Minami","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Hokkaido Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Konno","sequence":"additional","affiliation":[{"name":"Department of Neurology, Toho University Ohashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Nagane","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hanamaki General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiaki","family":"Utsugisawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hanamaki General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Punga AR, Maddison P, Heckmann JM, Guptill JT, Evoli A. Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Lancet Neurol 21: 176-188, 2022.","DOI":"10.1016\/S1474-4422(21)00297-0"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Sanders DB, Wolfe GI, Benatar M, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology 87: 419-425, 2016.","DOI":"10.1212\/WNL.0000000000002790"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Murai H, Utsugisawa K, Motomura M, Imai T, Uzawa A, Suzuki S. The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert-Eaton myasthenic syndrome. Clin Exp Neuroimmunol 14: 19-27, 2023.","DOI":"10.1111\/cen3.12739"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Uzawa A, Suzuki S, Kuwabara S, et al. Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis. J Neurol Neurosurg Psychiatry 94: 467-473, 2023.","DOI":"10.1136\/jnnp-2022-330519"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Uzawa A, Utsugisawa K. Biological therapies for myasthenia gravis. Expert Opin Biol Ther 23: 253-260, 2023.","DOI":"10.1080\/14712598.2023.2184257"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Johnson S, Katyal N, Narula N, Govindarajan R. Adverse side effects associated with corticosteroid therapy: a study in 39 patients with generalized myasthenia gravis. Med Sci Monit 27: e933296, 2021.","DOI":"10.12659\/MSM.933296"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Masuda M, Utsugisawa K, Suzuki S, et al. The MG-QOL15 Japanese version: validation and associations with clinical factors. Muscle Nerve 46: 166-173, 2012.","DOI":"10.1002\/mus.23398"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Blakey J, Chung LP, McDonald VM, et al. Oral corticosteroids stewardship for asthma in adults and adolescents: a position paper from the Thoracic Society of Australia and New Zealand. Respirology 26: 1112-1130, 2021.","DOI":"10.1111\/resp.14147"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Costello R, Patel R, Humphreys J, McBeth J, Dixon WG. Patient perceptions of glucocorticoid side effects: a cross-sectional survey of users in an online health community. BMJ Open 7: e014603, 2017.","DOI":"10.1136\/bmjopen-2016-014603"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Utsugisawa K, Suzuki S, Nagane Y, et al. Health-related quality-of-life and treatment targets in myasthenia gravis. Muscle Nerve 50: 493-500, 2014.","DOI":"10.1002\/mus.24213"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Huscher D, Thiele K, Gromnica-Ihle E, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 68: 1119-1124, 2009.","DOI":"10.1136\/ard.2008.092163"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Suzuki S, Masuda M, Uzawa A, et al. Japan MG registry: chronological surveys over 10 years. Clin Exp Neuroimmunol 14: 5-12, 2023.","DOI":"10.1111\/cen3.12731"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lee I, Kaminski HJ, McPherson T, Feese M, Cutter G. Gender differences in prednisone adverse effects: survey result from the MG registry. Neurol Neuroimmunol Neuroinflamm 5: e507, 2018.","DOI":"10.1212\/NXI.0000000000000507"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/24\/64_5678-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T03:39:56Z","timestamp":1766201996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/24\/64_5678-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":13,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5678-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"article-number":"5678-25"}}